Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Conmed (CNMD) Shares Outstanding (2016 - 2025)

Conmed's Shares Outstanding history spans 16 years, with the latest figure at $31.3 million for Q4 2025.

  • For Q4 2025, Shares Outstanding changed 0.0% year-over-year to $31.3 million; the TTM value through Dec 2025 reached $31.3 million, changed 0.0%, while the annual FY2025 figure was $31.3 million, 0.0% changed from the prior year.
  • Shares Outstanding reached $31.3 million in Q4 2025 per CNMD's latest filing, roughly flat from $31.3 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $31.3 million in Q1 2021 to a low of $31.3 million in Q4 2021.
  • Average Shares Outstanding over 5 years is $31.3 million, with a median of $31.3 million recorded in 2021.
  • Peak YoY movement for Shares Outstanding: decreased 0.0% in 2021, then rose 0.0% in 2022.
  • A 5-year view of Shares Outstanding shows it stood at $31.3 million in 2021, then changed by 0.0% to $31.3 million in 2022, then changed by 0.0% to $31.3 million in 2023, then changed by 0.0% to $31.3 million in 2024, then increased by 0.0% to $31.3 million in 2025.
  • Per Business Quant, the three most recent readings for CNMD's Shares Outstanding are $31.3 million (Q4 2025), $31.3 million (Q3 2025), and $31.3 million (Q2 2025).